GlassScriptPhysician profile
Sheri L Rowen
NPI 1548203904
$1,007,666.15
in general payments reported to CMS, 2019-2025
38 companies · $213K in 2025
The $213K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210K · 2020: $25K · 2021: $78K · 2022: $174K · 2023: $166K · 2024: $142K · 2025: $213K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $205K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $169K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $82K · Travel and Lodging: $37K · Food and Beverage: $26K · Honoraria: $3,326 · Entertainment: $18.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $204,925.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $168,556.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $81,927.50 |
| Travel and Lodging | $36,893.51 |
| Food and Beverage | $25,597.73 |
| Honoraria | $3,325.59 |
| Entertainment | $18.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $289,471.74 | 2022-2025 | Miebo, Xiidra, Crystalens Accommodating Iol (At-52ao) |
| Alcon Vision LLC | $149,884.73 | 2019-2025 | Tryptyr, Acrysof Iq Panoptix Uv Iol, Clareon |
| Oyster Point Pharma, INC. | $125,233.02 | 2022-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $106,622.81 | 2019-2021 | |
| Alcon Research LLC | $97,564.81 | 2019-2025 | Tryptyr |
| Rxsight INC | $79,164.70 | 2020-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Dompe US, INC. | $40,594.07 | 2019-2025 | Oxervate |
| Shire North American Group INC | $28,141.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $20,221.45 | 2019-2023 | |
| Kala Pharmaceuticals, INC. | $11,500.77 | 2019-2022 | |
| Allergan, INC. | $8,719.03 | 2019-2022 | |
| Glaukos Corporation | $5,652.58 | 2019-2025 | Idosetr, Istent Infinite, Photrexa Viscous and Photrexa |
| Tarsus Pharmaceuticals, INC. | $5,531.46 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $5,494.52 | 2019-2025 | Catalys System, Compact Intuitiv, Ifs Advanced Femtosec Laser |
| Abbvie INC. | $5,353.25 | 2022-2025 | Vuity, Lumigan, Combigan |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $3,843.70 | 2019-2021 | |
| Omeros Corporation | $3,527.44 | 2019 | |
| Biotissue Holdings INC. | $2,679.70 | 2019-2025 | |
| Sight Sciences, INC. | $2,507.30 | 2019-2023 | Tearcare System, Omni Surgical System |
| Horizon Therapeutics Plc | $2,020.80 | 2023 | Tepezza |
| Lensar, INC. | $1,729.83 | 2019-2023 | Lensar Laser System |
| Eyevance Pharmaceuticals LLC | $1,692.34 | 2019-2021 | |
| Harrow Eye, LLC | $1,571.82 | 2023-2025 | Vevye, Iheezo |
| Optos, INC. | $1,518.21 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Thea Pharma INC. | $1,473.33 | 2022-2023 | |
| Eyepoint US, INC. | $1,326.23 | 2019-2020 | |
| Ivantis, INC | $1,276.09 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $1,196.53 | 2019-2025 | Cequa |
| Mallinckrodt Hospital Products INC. | $402.58 | 2023-2025 | Acthar |
| Ocular Therapeutix, INC. | $312.93 | 2019-2024 | Dextenza |
| Apellis Pharmaceuticals, INC. | $265.98 | 2022-2025 | Syfovre |
| Microsurgical Technology, INC. | $260.74 | 2024-2025 | |
| Aerie Pharmaceuticals, INC. | $213.38 | 2020-2021 | |
| Carl Zeiss Meditec USA, INC. | $203.87 | 2021-2022 | |
| Staar Surgical Company | $182.29 | 2019 | |
| Ani Pharmaceuticals, INC. | $149.45 | 2025 | Purified Cortrophin Gel |
| Bausch Health US, LLC | $102.44 | 2020 | |
| Rayner Intraocular Lenses Limited | $58.92 | 2023-2024 | Omidria, Rayone Spheric, Rayone Emv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheri Rowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.